As we head into the fall season, respiratory viruses like flu, RSV, and COVID-19 are expected to spread as people gather indoors. To combat this, new COVID vaccines from Pfizer-BioNTech, Moderna, and Novavax are available this season. Here’s what you need to know about the Novavax protein-based vaccine.
Novavax is a protein-based vaccine that targets the virus in a more traditional way compared to mRNA vaccines like Moderna and Pfizer. It uses an insect virus that has been genetically engineered to express spike proteins, which are then incorporated into the vaccine. The vaccine also includes an immune system booster called an adjuvant to increase its immunity.
Adults have a choice between mRNA vaccines or Novavax for COVID vaccination this season. While Novavax may be appealing to those who want to experiment with the “mix-and-match” approach to COVID boosters, it’s essential to note that each vaccine has its own use cases and benefits.
Novavax is authorized by the FDA for adults 12 and older and has been found to have fewer short-term side effects compared to mRNA vaccines. However, side effects can vary by person, and more research is needed to confirm this.
In general, all COVID vaccines, including Novavax, may cause flu-like symptoms post-vaccine, such as headache, tiredness, and a sore arm. Rare cases of myocarditis or heart inflammation problems have also been associated with COVID vaccination, particularly in younger men and adolescents within two weeks following vaccination.
To find a Novavax vaccine near you, visit the Novavax website and type your ZIP code in the search box to see available pharmacies and doses. As always, it’s essential to consult with a healthcare professional before getting vaccinated and follow local guidelines for COVID-19 vaccinations.
Source: https://www.cnet.com/health/medical/move-over-mrna-what-to-know-about-the-novavax-covid-vaccine/